Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Euronext Paris  >  PCAS    PCA   FR0000053514

PCAS (PCA)

75
SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

PCAS : quarterly financial reporting Sep 30, 2011

10/07/2011 | 11:40am US/Eastern

Quarterly financial reporting
As of 30 September 2011

 

 

Business update

 

(in thousands of euros)20112010% change
 First Quarter44,05341,4346,3%
 including Pharmaceutical Synthesis27,14726,6032,0%
 including Specialty Chemicals16,90614,83114,0%
 Second Quarter41,78942,698-2,1%
 including Pharmaceutical Synthesis26,45728,100-5,8%
 including Specialty Chemicals15,33214,5985,0%
 Third Quarter33,48133,658-0,5%
 including Pharmaceutical Synthesis19,53018,3946,2%
 including Specialty Chemicals13,95115,264-8,6%
 Total as of 30 September119,323117,7901,3%
 including Pharmaceutical Synthesis73,13473,0970,1%
 including Specialty Chemicals46,18944,6933,3%

 

 

 

The PCAS Group's consolidated revenues at 30 September 2011came in 1.3% higher than the same period the previous year.

 

Pharmaceutical Synthesis
Over the first five months of the year, business was affected by the planned reduction in the contribution by the new contract between PCAS and Sanofi, effective since 31 May 2010. Excluding this contract, the Exclusive and Non-Exclusive Pharma business is up 10.5% at 30 September 2011.
Fine Specialty Chemicals
With growth of 3.3% at 30 September 2011, the Fine Specialty Chemicals business contracted by 8.6% during the third quarter of 2011 in relation to 2010, reflecting the economic slowdown seen since the summer.

 

Key operations and events for the quarter

 

No important events likely to have a significant impact on the company's business or situation occurred during the third quarter of 2011.

 

Outlook for the current year

 

The high level of sales expected for the fourth quarter should lead to earnings growth in 2011.

 

 

Next date :  2011 earnings, February 22nd, 2012

 

 

About PCAS
PCAS is a fine and specialty chemicals group that shares an ambition for excellence with its customers, which primarily include market-leading international groups. PCAS designs and delivers the best industrial solutions for its customers' specific expectations. These various expectations all share a common demand for safety, quality, competitiveness, innovation and sustainability.

 

Longjumeau, October 7th, 2011

 

PCAS_T3_2011_EN:
http://hugin.info/143512/R/1553112/478624.pdf



This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.

The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the
information contained therein.

Source: PCAS via Thomson Reuters ONE

HUG#1553112
React to this article
Latest news on PCAS
06/30 PCAS : reinforces its management team and hires several new staff members within..
06/30 PCAS : reinforces its management team and hires several new staff members within..
06/09 PCAS : Strengthens its foothold in pharmaceuticals in north america
06/02 PCAS : 2015 - 2016 financial calendar
05/26 PCAS : Obtains the "innovative business" label awarded by bpifrance
04/27 PCAS : ex-dividend day for annual dividend
04/21 PCAS : Sales as of march 31, 2015
03/27 PCAS : Confirmation of PEA-PME plan eligibility for 2015/2016
03/18 PCAS : MOONLINER® by ENERSENS: ultra-insulating natural-based wall cladding
02/19 PCAS : 2014 Results - Strong Financials and growth prospects lead to return to d..
Advertisement
Chart
Duration : Period :
PCAS Technical Analysis Chart | PCA | FR0000053514 | 4-Traders
Income Statement Evolution
More Financials